Prolactin as a Potential Biomarker of Glycemic Control in Women with Type 2 Diabetes Mellitus

Hashim Abed Abass; Salih Mahdi Salih

doi:10.61132/obat.v3i4.1441

Authors

Hashim Abed Abass University of Diyala
Salih Mahdi Salih University of Diyala

DOI:

https://doi.org/10.61132/obat.v3i4.1441

Keywords:

Fasting Blood Glucose, Glycemic Control, HbA1c, Prolactin

Abstract

Prolactin, a hormone primarily known for its important role in lactation and reproductive function have recently been implicated in metabolic-processes including glucose regulation. This study aims to investigation the relationship between serum prolactin levels and markers of glucose metabolism—specifically HbA1c and fasting blood glucose (FBG)—in women with T2DM. A cross sectional study was conducted on 100 adult female patients with T2DM, aged 35–50 years. Participants were classified based on HbA1c into three groups: good (≤7.0%), moderate (7.1–8.5%), and poor (≥8.6%) glycemic control. They were also stratified into low, normal, and high prolactin level groups. Serum prolactin was measured by ELISA, HbA1c by HPLC, and FBG using an automated analyzer. Statistical analysis was performed with significance at p ≤ 0.05. Although prolactin levels tended to increase with worsening HbA1c, the difference among HbA1c groups was not statistically significant. However, when stratified by prolactin levels, women in the high prolactin group had significantly higher HbA1c (7.38 ± 1.07%) and FBG (163.21 ± 25.23 mg/dL) compared to those in the low prolactin group (HbA1c: 6.82 ± 0.91%, FBG: 149.22 ± 22.24 mg/dL; p = 0.041 and p = 0.040, respectively). Elevated serum prolactin levels may be associated with poorer glycemic control in women with T2DM. These results showing the potential-role of prolactin hormone as a supplementary test in measuring glucose metabolism.

Downloads

Download data is not yet available.

References

Abed, H. H., Ali, A. M., & Al-Ziaydi, A. G. (2023). Evaluation level of serum vitamin B12 in Iraqi patients with diabetes mellitus type 2, who used the metformin drug as a hypoglycemic agent. Pakistan Journal of Pharmaceutical Sciences, 36(2), 425–429.

Abed, H. H., Alwasiti, E., & Tawfeeq, A. T. (2020). Titanium nanoparticles conjugated with streptokinase as a modified thrombolytic agent. International Journal of Current Pharmaceutical Research, 11(2), 18–25.

Ali, A. M., Abed, H. H., Al-Ziaydi, A. G., & Nayif, E. M. (2020). Evaluation of plasma protein alpha 2 and beta in the patients of hepatitis B and C virus by radial immunodiffusion technique (RID). Indian Journal of Public Health, 11(8), 271.

Ali, A. M., Abed, H. H., Nayif, E. M., & Salman, H. A. (2024). Study of albumin, C-reactive protein and calprotectin as non-invasive indicators for the diagnosis and differentiation of inflammatory bowel disease. Siberian Journal of Life Sciences and Agriculture, 16(2), 166–181.

Ali, A. M., Hussein, N. A., Jawad, D., Abed, H. H., & Mekkey, S. M. (2024). Hepatotoxic effects of Stevia rebaudiana leaf extract and commercial stevia on rats: A comparative study. Review of Clinical Pharmacology and Pharmacokinetics, 38(2), 69–72.

Corona, G., Rastrelli, G., Comeglio, P., Guaraldi, F., Mazzatenta, D., Sforza, A., … Maggi, M. (2022). The metabolic role of prolactin: Systematic review, meta-analysis and preclinical considerations. Expert Review of Endocrinology & Metabolism, 17(6), 533–545.

Eizirik, D. L., Pasquali, L., & Cnop, M. (2020). Pancreatic β-cells in type 1 and type 2 diabetes mellitus: Different pathways to failure. Nature Reviews Endocrinology, 16(7), 349–362.

Ferrannini, E., Natali, A., Camastra, S., Nannipieri, M., Mari, A., Adam, K.-P., … Tuomi, T. (2013). Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes, 62(5), 1730–1737.

Gierach, M., Bruska-Sikorska, M., Rojek, M., & Junik, R. (2022). Hyperprolactinemia and insulin resistance. Endokrynologia Polska, 73(6), 959–967.

Gorvin, C. M. (2015). The prolactin receptor: Diverse and emerging roles in pathophysiology. Journal of Clinical & Translational Endocrinology, 2(3), 85–91.

Gutiérrez, J., Gazzano, A., Torracca, B., Meucci, V., & Mariti, C. (2019). Determination of prolactin in canine saliva: Is it possible to use a commercial ELISA kit? Animals, 9(7), 418.

Ighodaro, O., & Adeosun, A. (2018). Vascular complications in diabetes mellitus. Kidney, 4, 16–19.

Ketema, E. B., & Kibret, K. T. (2015). Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control: Systematic review and meta-analysis. Archives of Public Health, 73, 1–9.

Khunti, K., Zaccardi, F., Amod, A., Aroda, V. R., Aschner, P., Colagiuri, S., … Chan, J. C. N. (2025). Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management. Diabetologia, 68(1), 17–28.

Kolb, H., & Martin, S. (2017). Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes. BMC Medicine, 15, 1–11.

Lopez‐Vicchi, F., De Winne, C., Brie, B., Sorianello, E., Ladyman, S. R., & Becu‐Villalobos, D. (2020). Metabolic functions of prolactin: Physiological and pathological aspects. Journal of Neuroendocrinology, 32(11), e12888.

Lundholm, M. D., Emanuele, M. A., Ashraf, A., & Nadeem, S. (2020). Applications and pitfalls of hemoglobin A1C and alternative methods of glycemic monitoring. Journal of Diabetes and Its Complications, 34(8), 107585.

Macotela, Y., Triebel, J., & Clapp, C. (2020). Time for a new perspective on prolactin in metabolism. Trends in Endocrinology & Metabolism, 31(4), 276–286.

Manshaei, N., Shakibaei, F., Fazilati, M., Salavati, H., Negahdary, M., & Palizban, A. (2019). An investigation of the association between the level of prolactin in serum and type II diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13(5), 3035–3041.

Mastnak, L., Herman, R., Ferjan, S., Janež, A., & Jensterle, M. (2023). Prolactin in polycystic ovary syndrome: Metabolic effects and therapeutic prospects. Life, 13(11), 2124.

Molina-Calle, M., De Medina, V. S., De La Torre, M. P. D., Priego-Capote, F., & De Castro, M. D. L. (2016). Development and application of a quantitative method based on LC–QqQ MS/MS for determination of steviol glycosides in Stevia leaves. Talanta, 154, 263–269.

Nair, G. G., Tzanakakis, E. S., & Hebrok, M. (2020). Emerging routes to the generation of functional β-cells for diabetes mellitus cell therapy. Nature Reviews Endocrinology, 16(9), 506–518.

Ni, Y., Chen, Q., Cai, J., Xiao, L., & Zhang, J. (2021). Three lactation-related hormones: Regulation of hypothalamus-pituitary axis and function on lactation. Molecular and Cellular Endocrinology, 520, 111084.

Nolan, C. J., & Prentki, M. (2019). Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift. Diabetes and Vascular Disease Research, 16(2), 118–127.

Pirchio, R., Graziadio, C., Colao, A., Pivonello, R., & Auriemma, R. S. (2022). Metabolic effects of prolactin. Frontiers in Endocrinology, 13, 1015520.

Rob, A., Hoque, A., Asaduzzaman, M. M., Khatoon, M. A. A., Khalil, R., Thomas, D., … Chowdhury, T. A. (2025). The global challenges of type 2 diabetes. Bangladesh Journal of Medicine, 36(2), 92–98.

Rutter, G. A., Pullen, T. J., Hodson, D. J., & Martinez-Sanchez, A. (2015). Pancreatic β-cell identity, glucose sensing and the control of insulin secretion. Biochemical Journal, 466(2), 203–218.

Teo, Z. L., Tham, Y.-C., Yu, M., Chee, M. L., Rim, T. H., Cheung, N., … Lu, Y. (2021). Global prevalence of diabetic retinopathy and projection of burden through 2045: Systematic review and meta-analysis. Ophthalmology, 128(11), 1580–1591.

Wang, T., Lu, J., Xu, Y., Li, M., Sun, J., Zhang, J., … Bi, Y. (2013). Circulating prolactin associates with diabetes and impaired glucose regulation: A population-based study. Diabetes Care, 36(7), 1974–1980.

Yang, H., Lin, J., Li, H., Liu, Z., Chen, X., & Chen, Q. (2021). Prolactin is associated with insulin resistance and beta-cell dysfunction in infertile women with polycystic ovary syndrome. Frontiers in Endocrinology, 12, 571229.